Tag: NASDAQ:ALNY

FB Nasdaq FB Facebook
Finance

Hot BiotecH Stocks: Alnylam Pharmaceuticals (NASDAQ:ALNY), Sangamo Biosciences (NASDAQ:SGMO), Dyax Corp. (NASDAQ:DYAX), Synthetic Biologics Inc (NYSEMKT:SYN)

It was the biggest loser on the Bloomberg Massachusetts Index: Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), down more than 12 percent. The Cambridge company is developing a new class of medicines based on RNA interference, or RNAi. Alnylam believes that RNAi therapeutics are a promising approach to silence disease-causing genes, according to its website. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock performance was -12.11% in last session and finished … Continue reading Hot BiotecH Stocks: Alnylam Pharmaceuticals (NASDAQ:ALNY), Sangamo Biosciences (NASDAQ:SGMO), Dyax Corp. (NASDAQ:DYAX), Synthetic Biologics Inc (NYSEMKT:SYN)

Kevin Long
Finance

Biotech Volatile Stocks: NewLink Genetics Corp (NASDAQ:NLNK), Alnylam Pharmaceuticals (NASDAQ:ALNY), Kindred Biosciences (NASDAQ:KIN), Agenus (NASDAQ:AGEN)

NewLink Genetics Corp (NASDAQ:NLNK)’s algenpantucel-L is expected to garner the highest sales and will be launched in both resectable and unresectable locally-advanced settings. Other drugs with significant forecast sales by 2017 include Threshold Pharmaceuticals/Merck’s TH-302 and Merrimack Pharmaceuticals’ MM-398,” director says. NewLink Genetics Corp (NASDAQ:NLNK) stock performance was -9.03% in last session and finished the day at $24.98. Traded volume was 808,573.00million shares in the … Continue reading Biotech Volatile Stocks: NewLink Genetics Corp (NASDAQ:NLNK), Alnylam Pharmaceuticals (NASDAQ:ALNY), Kindred Biosciences (NASDAQ:KIN), Agenus (NASDAQ:AGEN)

John Bellich
Diversified Tech

Mix Sector Stocks News: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Wipro Ltd. (NYSE:WIT), Franco-Nevada Corporation (NYSE:FNV), ICF International Inc. (NASDAQ:ICFI), Avnet, Inc. (NYSE:AVT)

On Jan 20, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $450 million. All of the shares in the offering are to be sold by Alnylam. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) belongs to Healthcare sector. Its weekly performance is -10.02%. On last trading day company shares ended up $93.17. … Continue reading Mix Sector Stocks News: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Wipro Ltd. (NYSE:WIT), Franco-Nevada Corporation (NYSE:FNV), ICF International Inc. (NASDAQ:ICFI), Avnet, Inc. (NYSE:AVT)

John Meady
Finance

Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Prosensa Holding NV (NASDAQ:RNA) was upgraded by stock analysts at KBC Securities from a “hold” rating to an “accumulate” rating in a report issued on Wednesday. The firm currently has a $11.00 price objective on the stock, up from their previous price objective of $7.00. KBC Securities’ target price would indicate a potential upside of 1.57% from the company’s current price. Prosensa Holding NV (NASDAQ:RNA) … Continue reading Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Colin Pettis
Finance

Mid Cap Bullish Stocks : Puma Biotechnology Inc (NYSE:PBYI), J2 Global Inc (NASDAQ:JCOM), Alnylam Pharmaceuticals (NASDAQ:ALNY), athenahealth (NASDAQ:ATHN)

Puma Biotechnology Inc (NYSE:PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 11:20 a.m. PDT on Wednesday, May 14, at the Bank of America Merrill Lynch 2014 Health Care Conference. The conference will be held at the Encore at the Wynn in Las Vegas. Puma Biotechnology … Continue reading Mid Cap Bullish Stocks : Puma Biotechnology Inc (NYSE:PBYI), J2 Global Inc (NASDAQ:JCOM), Alnylam Pharmaceuticals (NASDAQ:ALNY), athenahealth (NASDAQ:ATHN)

Chris Lewis